Quiz Maker LogoMake your own QuizCopy & Edit
Make your own quizManage my QuizzesPlans / FeaturesGuides and HelpContactPrivacy & Security

Molecular Pathology and Targeted Therapy Quiz

In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?
HRD status
Response to platinum-based therapy
Previous Platinum-free interval
For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?
15%
25%
50%
Which is the molecular type of endometrial carcinoma, most likely associated with good prognosis?
P53 abnormal
Non specific molecular profile
Mismatch Repair Deficient
Pole mutated
{"name":"Molecular Pathology and Targeted Therapy Quiz", "url":"https://www.quiz-maker.com/QPREVIEW","txt":"In recurrent ovarian cancer, which factor best identifies patients who could benefit from PARP inhibitors?, For First line therapy of High grade serous ovarian cancer with PARP inhibitors, what percentage of patients have HRD in the tumour?, Please enter your email address","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}

More Quizzes

Klausimai apie paukščius
20100
How Naturally Gifted are you? - NO INTERNET ALLOWED
12633
SDC INSTITUTE FOR VOAA - ACCREDITATION
1050
What does Liz prefer?
1269
Helledussen ØL-QUIZ
1580
LE - I
1050
James I
5238
Help a dumb writer
100
How much are you like Blas? (part 2)
1050
Do you think potatoes r g00d?
100
Alzheimer's Trivia!
1167
Guess the correct food and drinks
100
Quiz Maker Logo Make your own Quiz
Powered by: Quiz Maker